Diseases [C] » Respiratory Tract Diseases [C08] » Lung Diseases » Lung Injury » Acute Lung Injury
Description
A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological). MeSH
Hierarchy View
Subtype Terms (1)
Transfusion-Related Acute Lung Injury
4 approved drugs
Approved Indicated Drugs (1)
Phase 2 Indicated Drugs (26)
Phase 1 Indicated Drugs (9)
Other Experimental Indicated Drugs (8)
Organization Involved with Phase 4 Indications (23)
Hospital General Universitario Gregorio Marañon
Huazhong University of Science and Technology
I.M. Sechenov First Moscow State Medical University
Organization Involved with Phase 3 Indications (103)
Ache Laboratorios Farmaceuticos S.A.
Adolphe Rothschild Ophtalmologic Foundation
Albert Einstein Israelite Hospital
Assistance Publique - Hôpitaux de Paris
Blekinge County Council Hospital
Brazilian Research In Intensive Care Network
Catholic University of Sacred Heart, Rome
Centre Chirurgical Marie Lannelongue
Centre Hospitalier de Saint-Brieuc
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
Faculty of Medicine Universitas Indonesia - Dr Cipto Mangunkusumo Hospital
Federal University of Juiz de Fora
Groupe Hospitalier Bretagne Sud
Groupe Hospitalier Diaconesses Croix Saint Simon
Groupe Hospitalier Sud Ile-de-France
Groupe Hospitalier Universitaire Paris psychiatrie & neurosciences
Icahn School of Medicine at Mount Sinai
Laboratoire français de Fractionnement et de Biotechnologies
Pneuma Pharmaceuticals Incorporated
Shahid Beheshti University of Medical Sciences
The University of Texas, Dallas
University of British Columbia
University of California, Berkeley
University of California, San Diego
University of California, San Francisco
Organization Involved with Phase 2 Indications (128)
Acute Respiratory Distress Syndrome Foundation
American Society for Parenteral and Enteral Nutrition
A.O. Ospedale Maggiore di Lodi
Apeptico Forschung und Entwicklung GmbH
Autonomous University of Madrid
Chinese Academy of Medical Sciences
Claude D. Pepper Older Americans Independence Center
Federal University of Rio de Janeiro
Harborview Injury Prevention and Research Center
Hospital of Mantes-la-Jolie, France
Hospital Regional de Alta Especialidad de Zumpango
Institut de Cancerologie Strasbourg Europe
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Kyoto Prefectural University of Medicine
Methodist Research Institute, Indianapolis
National Center for Research Resources (NCRR)
National Institutes of Health (NIH)
National Polytechnic Institute, Mexico
National Research Center, Egypt
National University of Ireland
Northern Ireland Clinical Trials Unit
Oregon Health and Science University
Organicell Regenerative Medicine, Inc
People's Liberation Army of China
Rio de Janeiro Federal University
Organization Involved with Other Experimental Indications (11)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.